Skip to content
10-Q

Quarterly Report

CANCER CAPITAL CORP.

0001554795-21-000281

← back to feed
Filed
Aug 13, 2021 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2021 · Aug 13, 2021 6.15M sh
Current Liabilities Q2 2021 · Jun 30, 2021 $351.8K
Current Liabilities Q2 2021 · Dec 31, 2020 $333.04K
Total Liabilities Q2 2021 · Jun 30, 2021 $351.8K
Total Liabilities Q2 2021 · Dec 31, 2020 $333.04K
Current Assets Q2 2021 · Jun 30, 2021 $1.2K
Current Assets Q2 2021 · Dec 31, 2020 $698
Total Assets Q2 2021 · Jun 30, 2021 $1.2K
Total Assets Q2 2021 · Dec 31, 2020 $698
Operating Cash Flow Q2 2021 · Jun 30, 2020 −$6.31K
Cash And Equivalents Q2 2021 · Jun 30, 2020 $108
Cash And Equivalents Q2 2021 · Dec 31, 2019 $218
Stockholders Equity Q2 2021 · Jun 30, 2020 −$318.2K
Stockholders Equity Q2 2021 · Mar 31, 2020 −$311.19K
Stockholders Equity Q2 2021 · Dec 31, 2019 −$301.59K
Sga Expense Q2 2021 · Jun 30, 2020 $2.7K
Sga Expense Q2 2021 · Jun 30, 2020 $8.11K
Net Income Q2 2021 · Jun 30, 2020 −$7.01K
Net Income Q2 2021 · Jun 30, 2020 −$16.62K
Net Income Q2 2021 · Mar 31, 2020 −$9.61K
Operating Income Q2 2021 · Jun 30, 2020 −$2.7K
Operating Income Q2 2021 · Jun 30, 2020 −$8.11K